Follow Health Care Reform Insider on Twitter
You are here:  Home  >  Emerging Healthcare Models  >  Current Article

Abbott’s St. Jude Deal Aligns With Shift To Value-Based Care

January 1, 2017 

The Federal Trade Commission’s approval of Abbott Laboratories $25 billion purchase of St. Jude Medical sets the larger company up for value-based care and bundled payments to doctors and hospitals.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>